$Histogenics(OCGN)$I turned bearish after seeing the numbers and earning calls. Fundamentally the company is weak. But good for trade or swing. Please be mindful US is having surplus vaccine. For Covaxin to be sold in US they'll need EUA approval ASAP.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Qaal·2021-05-08And EUA submission has been delayed till maybe June. Master file sent to FDA. No sales from ocugen yet. 45% profit from a 10bucks per vacc. You gotta account for 1.5b market cap. Think guys. DyoddLikeReport